RARA and rheumatoid arthritis: miR-10a directly targets not only Bcl-6, a master positive regulator of TFH differentiation, but also nuclear receptor corepressor 2 (Ncor2), a corepressor of RARα and, in so doing, activates a positive feedback loop that amplifies its own induction by RA.